An experimental immunotherapy drug called VIR-5500 has driven prostate-specific antigen (PSA) levels down by as much as 99% in some men with metastatic castration-resistant prostate cancer, according ...

Our immune system is great at fighting many types of cancer, but it struggles to see prostate tumors. While new treatments ...

The average age of men who get diagnosed is 67.

A new combination of drugs could help delay the advancement of a deadly form of prostate cancer in those with an advanced form of the disease, new research has found. The “striking” findings showed an ...

A new prostate cancer treatment could mean men suffer fewer side effects, scientists say. Trials will examine whether aquablation – a therapy using robotics, AI and real-time imaging – works as well ...

A new drug for advanced prostate cancer has shown promise in early trials experts have said, with the medication shrinking tumors in some patients. Prostate cancer is the most common cancer among men ...

New prostate cancer drug showing ‘remarkable’ results during clinical trial - The new drug, known as VIR-5500, uses a ...

A drug for advanced prostate cancer has shown "remarkable" results in an early-stage trial, experts have said.

Prostate cancer is the second most common cancer diagnosis in men. 1 in 8 men will be diagnosed with the disease during their lifetime. Dr. Jose Avita from the New Mexico Cancer Center talked about ...

Florida State University researchers are working on new approaches to deciphering genetic data that may lead to new, more targeted prostate cancer treatments. Prostate cancer, which affects one in ...

A new study using serial liquid biopsies to track how metastatic prostate cancer evolves under treatment pressure showed that ...